For instance, ctDNA analysis has been successfully used to detect resistant mutations in genes such as EGFR [29,47], ERBB2 [43], PIK3CA, and RAS [28,50], in various cancers including NSCLC [28,29,47], CRC [50], and gastric cancer [43]. This evidence concerns the gene ERBB2 and non-small cell lung carcinoma.